A patient with recalcitrant oral pemphigus vulgaris successfully treated with a biologic drug- Rituximab
Pemphigus vulgaris (PV) is a chronic autoimmune blistering disease affecting mucous membranes and the skin. Rituximab (RTX), a monoclonal antibody against CD20, has been approved by FDA for the treatment of adults with moderate to severe PV. A 42-year-old Indian woman, previously diagnosed with oral...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Online |
| Lingua: | inglese |
| Pubblicazione: |
International Association for Dental Research (Nigeria Division)
2019
|
| Accesso online: | https://ajoh.oauife.edu.ng/index.php/ajoh/article/view/41 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Lascia un commento!